Alessandra Lugaresi

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 218 publications

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 21, 2026

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 02, 2026

Case Report: Multiple sclerosis and Neurofibromatosis type 1: a rare comorbidity.

Case Report: Multiple sclerosis and Neurofibromatosis type 1: a rare comorbidity.

Journal: Frontiers in neurology

Published: April 30, 2026

The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study.

The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study.

Journal: Multiple sclerosis and related disorders

Published: March 23, 2026

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Journal: Journal of neurology

Published: March 22, 2026

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Journal: Brain : a journal of neurology

Published: March 12, 2026

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

Journal: Journal of neurology

Published: December 05, 2025

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Journal: Neurology

Published: November 24, 2025

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open

Published: November 03, 2025

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Journal: Journal of neurology

Published: November 01, 2025

Abuse in individuals with multiple sclerosis: the SocialMS Italian study.

Abuse in individuals with multiple sclerosis: the SocialMS Italian study.

Journal: Multiple sclerosis and related disorders

Published: October 13, 2025

Showing 1-12 of 218

Last Updated: 09/26/2026